BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11427542)

  • 1. Potential impact of the VITEK 2 system and the Advanced Expert System on the clinical laboratory of a university-based hospital.
    Sanders CC; Peyret M; Moland ES; Cavalieri SJ; Shubert C; Thomson KS; Boeufgras JM; Sanders WE
    J Clin Microbiol; 2001 Jul; 39(7):2379-85. PubMed ID: 11427542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ability of the VITEK 2 advanced expert system To identify beta-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosa.
    Sanders CC; Peyret M; Moland ES; Shubert C; Thomson KS; Boeufgras JM; Sanders WE
    J Clin Microbiol; 2000 Feb; 38(2):570-4. PubMed ID: 10655347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of workflow and accuracy of identification and antimicrobial susceptibility testing of clinical isolates of Enterobacteriaceae, Pseudomonas aeruginosa and enterococci by Vitek 2 and routine methods.
    Rantakokko-Jalava K; Elo-Lehtonen E; Meurman O
    APMIS; 2006 Jan; 114(1):43-9. PubMed ID: 16499660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory-based evaluation of the colorimetric VITEK-2 Compact system for species identification and of the Advanced Expert System for detection of antimicrobial resistances: VITEK-2 Compact system identification and antimicrobial susceptibility testing.
    Nakasone I; Kinjo T; Yamane N; Kisanuki K; Shiohira CM
    Diagn Microbiol Infect Dis; 2007 Jun; 58(2):191-8. PubMed ID: 17300904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of staphylococci by Phoenix: validation of a new protocol and comparison with Vitek 2.
    Chatzigeorgiou KS; Siafakas N; Petinaki E; Argyropoulou A; Tarpatzi A; Bobola M; Paniara O; Velegraki A; Zerva L
    Diagn Microbiol Infect Dis; 2010 Dec; 68(4):375-81. PubMed ID: 21094424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of disk diffusion, VITEK 2, and broth microdilution antimicrobial susceptibility test results for unusual species of Enterobacteriaceae.
    Stone ND; O'Hara CM; Williams PP; McGowan JE; Tenover FC
    J Clin Microbiol; 2007 Feb; 45(2):340-6. PubMed ID: 17135429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital.
    Raja NS; Singh NN
    J Microbiol Immunol Infect; 2007 Feb; 40(1):45-9. PubMed ID: 17332906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracies of beta-lactam susceptibility test results for Pseudomonas aeruginosa with four automated systems (BD Phoenix, MicroScan WalkAway, Vitek, and Vitek 2).
    Juretschko S; Labombardi VJ; Lerner SA; Schreckenberger PC;
    J Clin Microbiol; 2007 Apr; 45(4):1339-42. PubMed ID: 17229867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of RAISUS, a novel system for identification and antimicrobial susceptibility testing for enterococci.
    Kanemitsu K; Kunishima H; Inden K; Hatta M; Saga T; Ueno K; Harigae H; Ishizawa K; Kaku M
    Diagn Microbiol Infect Dis; 2005 Sep; 53(1):23-7. PubMed ID: 15994047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agents.
    Sader HS; Fritsche TR; Jones RN
    J Clin Microbiol; 2006 Mar; 44(3):1101-4. PubMed ID: 16517904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin.
    Tan TY; Ng SY
    Clin Microbiol Infect; 2007 May; 13(5):541-4. PubMed ID: 17371537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Microbiological study of 386 strains of Pseudomonas aeruginosa isolated in a 30-month span in the Isernia area with special reference to an antimicrobial assay carried out with the ABAC system on 214 of them].
    Laurelli T; Ricci N; Ottaviano R; Manuppella AM; Petescia G
    Quad Sclavo Diagn; 1985 Dec; 21(4):469-82. PubMed ID: 3939383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Performance evaluation of VITEK 2 system in meropenem susceptibility testing of clinical Pseudomonas aeruginosa isolates].
    Acuner IC; Bayramoğlu G; Birinci A; Cekiç Cihan C; Bek Y; Durupınar B
    Mikrobiyol Bul; 2011 Jul; 45(3):411-21. PubMed ID: 21935774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of VITEK 2 rapid identification and susceptibility testing system against gram-negative clinical isolates.
    Ling TK; Tam PC; Liu ZK; Cheng AF
    J Clin Microbiol; 2001 Aug; 39(8):2964-6. PubMed ID: 11474023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of disc diffusion methods and Vitek 2 automated system for testing susceptibility to mupirocin in Staphylococcus aureus.
    Malaviolle X; Nonhoff C; Denis O; Rottiers S; Struelens MJ
    J Antimicrob Chemother; 2008 Nov; 62(5):1018-23. PubMed ID: 18765413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of the VITEK 2 Advanced Expert System for identification of extended-spectrum beta-lactamase production in Enterobacter spp.
    Schwaber MJ; Navon-Venezia S; Chmelnitsky I; Leavitt A; Schwartz D; Carmeli Y
    J Clin Microbiol; 2006 Jan; 44(1):241-3. PubMed ID: 16390981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of the VITEK 2 Advanced Expert System (AES) in five UK hospitals.
    Barry J; Brown A; Ensor V; Lakhani U; Petts D; Warren C; Winstanley T
    J Antimicrob Chemother; 2003 May; 51(5):1191-202. PubMed ID: 12697635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates.
    Spanu T; Sanguinetti M; Tumbarello M; D'Inzeo T; Fiori B; Posteraro B; Santangelo R; Cauda R; Fadda G
    J Clin Microbiol; 2006 Sep; 44(9):3257-62. PubMed ID: 16954257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of rapidity and quality for the VITEK susceptibility cards with 45 wells].
    Miyamoto H; Handa T; Inoue C; Murase M
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 1998; 9(2):55-8. PubMed ID: 10036375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 16S rRNA gene sequencing versus the API 20 NE system and the VITEK 2 ID-GNB card for identification of nonfermenting Gram-negative bacteria in the clinical laboratory.
    Bosshard PP; Zbinden R; Abels S; Böddinghaus B; Altwegg M; Böttger EC
    J Clin Microbiol; 2006 Apr; 44(4):1359-66. PubMed ID: 16597863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.